about
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbot...
Read More
3.80
0.23
(6.44%)
36,650.9
XNAS Volume
XNAS 24 Jun, 2026 11:36 AM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
BioAtla Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..